<i>De Novo</i> donor-specific anti-HLA antibody risk stratification in kidney transplantation using a combination of B cell and T cell molecular mismatch assessment. [PDF]
Chou-Wu E+3 more
europepmc +1 more source
Significance of antithrombocyte isoantibody in blood transfusion clinics.
Yoichi Shibata
openalex +2 more sources
<i>De novo</i> donor-specific HLA antibody development after kidney transplantation is impacted by PIRCHE II score and recipient age. [PDF]
Tian Y+4 more
europepmc +1 more source
Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study. [PDF]
Guo Z+6 more
europepmc +1 more source
Circulating Immune Complexes and Complement Activation in Sensitized Kidney Transplant Recipients. [PDF]
Trivyza MS+7 more
europepmc +1 more source
A case report of severe drug-induced immune hemolytic anemia caused by piperacillin. [PDF]
Zhao H, Chen J, Ou G.
europepmc +1 more source
Association between Respiratory Virus Infection and Development of <i>De Novo</i> Donor-Specific Antibody in Lung Transplant Recipients. [PDF]
Nellore A+4 more
europepmc +1 more source
Identification of feline erythrocyte antigen 6 and lack of alloimmunization to feline erythrocyte antigen 4 in cats. [PDF]
Ternisien T+3 more
europepmc +1 more source
Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: A cost-utility analysis. [PDF]
de Vos TW+9 more
europepmc +1 more source